Other

Dataset Information

0

Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: Minigene library DNA-seq

ABSTRACT: We developed a massively parallel reporter assay to determine the splicing effects of all mutations in the region comprising CD19 exons 1-3. Despite the great success of CART-19 (chimeric antigen receptor-armed autologous T-cells) immunotherapy to treat B-cell acute lymphoblastic leukaemia (B-ALL), many patients relapse due to loss of the targeted CD19 epitope. Since epitope loss can be caused by CD19 exon 2 mis-splicing, we set out to learn the regulatory code that controls CD19 alternative splicing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE182891 | GEO | 2022/06/05

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: Minigene library RNA-seq
2022-06-05 | GSE182892 | GEO
Other Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: PTBP1 iCLIP2 in NALM-6 cells
2022-06-05 | GSE182893 | GEO
Genomics Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: Minigene library DNA-seq
| PRJNA758171 | ENA
Genomics Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: Minigene library RNA-seq
| PRJNA758173 | ENA
Transcriptomics Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19
2020-05-19 | GSE136068 | GEO
Genomics CART-19 Responses in Human CD19 Transgenic Mice
| PRJNA398223 | ENA
Genomics Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
| PRJNA758168 | ENA
Genomics Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19
| PRJNA561160 | ENA
Genomics Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: PTBP1 iCLIP2 in NALM-6 cells
| PRJNA758172 | ENA
Transcriptomics GD2-CART cells and iPSC-derived GD2-CART cells (scRNA-Seq)
2023-10-25 | GSE245955 | GEO